 BURLINGTON, Mass. and JERUSALEM, June 22, 2022 GLOBE NEWSWIRE -- BrainsWay Ltd. NASDAQ TASE: BWAY BrainsWay or the Company, a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that Christopher von Jako, PhD, BrainsWays President, and Chief Executive Officer, will participate in a fireside chat and panel discussion at the H.C. Wainwright 1st Annual Mental Health Conference being held at the Lotte New York Palace Hotel on June 27, 2022. 